XML 42 R16.htm IDEA: XBRL DOCUMENT
v3.25.4

Income Taxes | 12 Months Ended
--- | ---
Dec. 31, 2025
Income Tax Disclosure [Abstract] |
Income Taxes | The following table presents the Company’s U.S. and foreign components of consolidated income before income taxes and the provision for income taxes.
| Years Ended December 31,
| 2025 |  | 2024 |  | 2023
| (In thousands)
Income before income taxes: |  |  |  |  |
U.S. | $27,423 |  | $25,608 |  | $22,592
Foreign | 172 |  | 127 |  | 113
Total income before income taxes | $27,595 |  | $25,735 |  | $22,705
Current tax provision: |  |  |  |  |
Federal | $2,692 |  | $1,266 |  | $1,268
State | 17 |  | 24 |  | 13
Foreign | 156 |  | 106 |  | 51
Current tax provision | 2,865 |  | 1,396 |  | 1,332
Deferred tax provision (benefit): |  |  |  |  |
Federal | 1,547 |  | 1,619 |  | (262)
State | 221 |  | (330) |  | 131
Total deferred tax provision (benefit) | 1,768 |  | 1,289 |  | (131)
Total provision for income taxes | $4,633 |  | $2,685 |  | $1,201
As discussed in Note 1, “Description of Business and Significant Accounting Policies”, the Company has elected to prospectively adopt the guidance in ASU 2023-09. The following table presents a reconciliation of income taxes computed at the statutory federal income tax rate to the effective tax rate implied by the accompanying Consolidated Statements of Operations for the year ended December 31, 2025 in accordance with ASU 2023-09.
| Amount |  | Percent
U.S. federal taxes at statutory rate | $5,795 |  | 21%
State and local income tax, net of federal benefit 1 | 243 |  | 1
Foreign rate differential | 57 |  | —
Effect of cross-border tax laws |  |  |
Foreign derived intangible income | (1,853) |  | (7)
Tax credits |  |  |
Research & development tax credits | (331) |  | (1)
Changes in Valuation Allowances |  |  |
Nontaxable or Nondeductible Items |  |  |
Stock-based compensation shortfalls | 275 |  | 1
Non-deductible compensation | 334 |  | 1
Other | 114 |  | 1
Changes in unrecognized tax benefits | (4) |  | —
Other | 3 |  | —
Provision for income taxes and effective tax rate | $4,633 |  | 17%
1 California makes up the majority of state tax expense in this category. The following table presents a reconciliation of income taxes computed at the statutory federal income tax rate to the effective tax rate implied by the accompanying Consolidated Statements of Operations for the years ended December 31, 2024 and December 31, 2023 in accordance with the guidance before the adoption of ASU 2023-09.
| Years Ended December 31,
| 2024 |  | 2023
U.S. federal taxes at statutory rate | 21% |  | 21%
Stock-based compensation | 2 |  | (1)
Non-deductible expenses | 1 |  | 1
Research and Development Tax Credits | (4) |  | (6)
Valuation allowance | (2) |  | —
Foreign derived intangible income | (8) |  | (10)
Effective tax rate | 10% |  | 5%
The following table presents the components of the Company’s net deferred tax asset, which is presented in other assets, non-current on the Consolidated Balance Sheets.
| December 31,
| 2025 |  | 2024
| (In thousands)
Deferred tax assets: |  |  |
Net operating loss carry forwards | $496 |  | $496
Amortization of research and experimental expenditures | 8,065 |  | 7,649
Accruals and reserves | 3,314 |  | 4,549
Operating lease liabilities | 2,067 |  | 2,474
Research and development, and foreign tax credit carry forwards | 4,954 |  | 4,908
Total deferred tax assets | 18,896 |  | 20,076
Valuation allowance | (4,740) |  | (4,425)
Total deferred tax assets, net of valuation allowance | 14,156 |  | 15,651
Deferred tax liabilities: |  |  |
Depreciation on property and equipment | (1,652) |  | (2,116)
Right of use asset | (1,679) |  | (2,110)
Other | (62) |  | (25)
Goodwill | (2,496) |  | (2,396)
Total deferred tax liabilities | (5,889) |  | (6,647)
Net deferred tax asset | $8,267 |  | $9,004
Valuation Allowance The following table presents the valuation allowance activities.
|  | Years Ended December 31,
|  | 2025 |  | 2024 |  | 2023
(In thousands) |
Balance, beginning of year |  | $4,425 |  | $4,600 |  | $4,185
Changes to valuation allowance |  | 315 |  | (175) |  | 415
Balance, end of year |  | $4,740 |  | $4,425 |  | $4,600
In asserting the recoverability of deferred tax assets, the Company considers whether it is more likely than not that the assets will be realized. The ultimate realization of deferred tax assets is dependent upon the generation of future taxable income during the periods in which those temporary differences become deductible. The Company assesses the available positive and negative evidence to estimate if sufficient future taxable income will be generated to use the existing deferred tax assets. In making such a determination, the Company considers all available positive and negative evidence, including recent results of operations, scheduled reversals of deferred tax liabilities, projected future income, tax law updates, and available tax planning strategies. A significant piece of objective positive evidence evaluated was the cumulative profit incurred in the U.S. On the basis of this evaluation, as of December 31, 2025, the Company continues to maintain a valuation allowance on its California research and development (“R&D”) credit carryovers of $4.7 million. In tax year 2024 California amended its tax laws to suspend the use of net operating loss carryovers of amounts over $1.0 million for the 2024 to 2026 tax years. As a result of this amendment, the Company recognized a deferred tax asset of California R&D credit carryovers of $0.2 million as of December 31, 2025. The Company will maintain a valuation allowance on its remaining California R&D credit carryovers because it is more likely than not that the Company will continue to annually generate more California R&D tax credits than it utilizes, resulting in no net reduction of credits. On July 4, 2025, the O ne Big Beautiful Bill Act (“OBBB”) was enacted by the U.S. federal government. The OBBB significantly modified the income tax treatment of research and development costs, allows companies to elect 100% bonus deprecation on qualified property as well as various aspects of foreign income, in each case as follows: 1) Research and Development Costs - The OBBB allows U.S. companies to elect to accelerate the deduction of the 2022 to 2024 year capitalized domestic R&D costs or continue to amortize these capitalized R&D costs over the remaining tax lives. The Company has elected to continue to amortize the capitalized domestic R&D costs over the remaining lives. In addition, the OBBB allows companies to expense versus capitalize domestic R&D costs for tax purposes beginning with the 2025 year. Alternatively, companies can elect to continue to capitalize domestic R&D costs. The Company will elect to continue to capitalize and amortize domestic R&D costs for U.S. federal income tax purposes. 2) Bonus Depreciation – The OBBB allows U.S. companies to elect 100% bonus deprecation on qualified property acquired and placed in service after January 19, 2025. This allows the Company to accelerate tax depreciation on qualified property. 3) Foreign Income and Global Intangible Low Taxed Income (“GILTI”) – The IRC Section 250 deduction on GILTI income was reduced from 50% to 40% for tax years beginning after December 31, 2025. In addition, the qualified business asset investment exemption was repealed. It is expected that this law change will have an immaterial impact to the Company. 4) Foreign Income and Foreign Derived Deduction Eligible Income (“FDDEI” (formerly Foreign Derived Intangible Income (“FDII”))) - The deduction was reduced from 37.5% of eligible income to 33.34% of eligible income for tax years beginning after December 31, 2025. In addition, the 10% qualified business asset investment reduction has been eliminated for tax years beginning after December 31, 2025. We expect that these changes will nominally raise the Company’s effective tax rate in future years. The Company continues to assert that the accumulated foreign earnings of its subsidiaries in Spain and Canada are permanently reinvested. Due to the U.S. Tax Cuts and Jobs Act (“Tax Act”) enacted in 2017, any future repatriation of the earnings of its subsidiaries in Spain and Canada would not be subject to U.S. federal income tax. The Company has estimated that the foreign withholding taxes and U.S. state income taxes related to a potential future repatriation of these earnings would be immaterial. The Company has evaluated the impact of the global intangible low taxed income (“GILTI”) and has concluded that the impact to the Company is immaterial. The following table presents the Company’s California net operating loss carryforward.
| Earliest Expiration Year |  | December 31,
|  | 2025 |  | 2024
|  |  | (In thousands)
California | 2034 |  | $6,822 |  | $6,822
Utilization of the California net operating loss carryforward may be subject to a substantial annual limitation due to the ownership change limitations provided by the California Revenue and Taxation Code which could result in the expiration of the net operating loss carryforward before utilization. As of December 31, 2025, there are no ownership change limits on the utilization of the California net operating loss carryforward. The following table presents the Company’s R&D credit by taxing authority, minimum tax credit and foreign tax credit carryforwards.
| Earliest Expiration Year |  | December 31,
|  | 2025 |  | 2024
|  |  | (In thousands)
California | No Expiration Date |  | 6,271 |  | 6,098
Utilization of the credit carryforwards may be subject to a substantial annual limitation due to the ownership change limitations provided by the U.S. Internal Revenue Code (“IRC”) and similar California provisions. As of December 31, 2025, there are no ownership change limits on the utilization of these net tax credit carryforwards. The following table presents the net cash paid by the Company for income taxes during the year ended December 31, 2025.
|  | December 31,
|  | 2025
|  | (In thousands)
Domestic |  |
Federal |  | $1,250
States |  | 8
Foreign |  |
Spain |  | 79
China |  | 51
Other |  | 10
Total cash paid for taxes, net of refunds |  | $1,398
Accounting for uncertain tax positions is based on judgment regarding the largest amount that is greater than 50% likely of being realized upon the ultimate settlement with a taxing authority. The following table presents the aggregate changes in the balance of the gross unrecognized tax benefits.
| Years Ended December 31,
| 2025 |  | 2024 |  | 2023
| (In thousands)
Gross unrecognized tax benefits, beginning of year | $1,862 |  | $1,705 |  | $1,505
Additions: |  |  |  |  |
Current year tax position | 87 |  | 170 |  | 184
Prior year tax position | 6 |  | — |  | 16
Reductions: |  |  |  |  |
Settlement | (136) |  | — |  | —
Prior year tax position | (9) |  | (13) |  | —
Gross unrecognized tax benefits, end of year | $1,810 |  | $1,862 |  | $1,705
As of December 31, 2025, the Company had unrecognized tax benefits of $1.8 million, of which $1.0 million, if recognized, would affect the Company’s effective tax rate. The Company adopted the accounting policy that interest and penalties are classified as part of its income taxes. As of December 31, 2025, there was no accrued interest or penaltie s associated with any unrecognized tax benefits. There are currently no examinations for U. S federal, state taxing authorities, and foreign tax authorities. The previously disclosed tax examination has been concluded with no material impact to the consolidated financial statements. The Company believes that, as of December 31, 2025, the gross unrecognized tax benefits will not materially change in the next twelve months. The Company believes that it has adequately provided for any reasonably foreseeable outcomes related to any tax audits and that any settlement will not have a material adverse effect on the consolidated financial position or results of operations. However, there can be no assurances as to the possible outcomes. The Organisation for Economic Cooperation and Development (“OECD”) developed Model Global Anti-Base Erosion (“GloBE”) rules (commonly referred to as Pillar II) establishing a Global Minimum Tax to ensure multinational enterprises with consolidated revenue of more than €750.0 million pay at least an effective tax rate of 15% on income arising in each jurisdiction in which they operate. Given the Company does not meet the minimum threshold, there is no impact to our tax provision for fiscal year 2025. The Company will continue to evaluate the impact of these tax law changes in future reporting periods.

X
- References No definition available. + Details
Name: | us-gaap_IncomeTaxDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for income tax. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 942 -SubTopic 740 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147477617/942-740-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480738/235-10-S50-1 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 944 -SubTopic 740 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147478822/944-740-50-1 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12 Reference 5: http://www.xbrl.org/2003/role/exampleRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 231 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482663/740-10-55-231 Reference 6: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12C -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12C Reference 7: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 12B -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-12B Reference 8: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 270 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Publisher FASB -URI https://asc.fasb.org/1943274/2147477891/740-270-50-1 Reference 9: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SAB Topic 6.I.5.Q1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-1 Reference 10: http://www.xbrl.org/2003/role/disclosureRef -Topic 946 -SubTopic 20 -Name Accounting Standards Codification -Section 50 -Paragraph 13 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480990/946-20-50-13 Reference 11: http://www.xbrl.org/2003/role/disclosureRef -Topic 235 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08(h)(2)) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1 Reference 12: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/740/tableOfContent Reference 13: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 14 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-14 Reference 14: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 21 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-21 Reference 15: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 17 -Subparagraph (b) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482685/740-10-50-17 Reference 16: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 10 -Name Accounting Standards Codification -Section S99 -Paragraph 2 -Subparagraph (SAB Topic 11.C) -Publisher FASB -URI https://asc.fasb.org/1943274/2147479360/740-10-S99-2 Reference 17: http://www.xbrl.org/2003/role/disclosureRef -Topic 740 -SubTopic 30 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (a) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482603/740-30-50-2 + Details
Name: | us-gaap_IncomeTaxDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration